How to get weight loss medication through the NHS England
GPs are now able to prescribe Mounjaro, but what are the eligibility requirements?

Key takeaways
- Access to Mounjaro in England is being rolled out gradually, starting with patients with a BMI ≥ 40 and multiple comorbidities, expanding over 3 years.
- NHS patients prescribed Mounjaro receive wraparound support, including diet, exercise, and psychological guidance, to ensure effective weight management.
- Those not meeting NHS criteria may still be eligible to access Mounjaro privately through Juniper, with a BMI of 30+ or 27+ with a weight-related condition, alongside expert-led holistic support.
Mounjaro, a new weight loss and type 2 diabetes treatment, was first launched in the UK in February 2024 for private patients. In December 2024, NICE approved Mounjaro for use within the NHS in England. Access is being introduced gradually, starting with patients at highest risk.
Who is eligible for Mounjaro via NHS GPs?
From 23 June 2025, patients in England can access Mounjaro through their GP if they meet strict eligibility criteria:
Year 1
- BMI ≥ 40 (or ≥ 37.5 for some ethnic groups)
- 4 or more weight-related comorbidities (e.g. type 2 diabetes, high blood pressure, sleep apnoea)
Year 2
- BMI 35 to 39.9
- Still require 4 or more co-morbidities
Year 3
- BMI ≥ 40
- 3 or more co-morbidities
This staged approach will reach 220,000 patients across the first three years. A full rollout is planned over 8 further years, eventually covering patients with BMI ≥ 35 and at least one comorbidity.
How do you get Mounjaro from your NHS GP?
GP practices will use NHS-approved tools to identify eligible patients. Those patients will:
- Be clinically assessed for suitability
- Be asked to join a structured weight management programme
- Be supported with diet, exercise, and behavioural advice
- Be prescribed Mounjaro by a GP or designated NHS prescriber
- Collect their prescription from a local pharmacy.
What support do NHS patients receive?
All NHS patients prescribed Mounjaro must also receive wraparound support, including:
- Dietitian or nutrition advice,
- Behavioural and psychological support,
- Physical activity guidance.
These services may be delivered by GP teams, Primary Care Networks (PCNs), or community providers.
Can you get Mounjaro on the NHS in Scotland, Wales or Northern Ireland?
No. Currently, the NHS Mounjaro rollout applies to England only. Patients in Scotland, Wales or Northern Ireland are not yet eligible through the NHS.
How can I access Mounjaro if I don’t meet NHS criteria?
If you don’t meet the strict NHS criteria, you may still be eligible for Mounjaro through Juniper.
At Juniper, you can access Mounjaro if you have:
- A BMI of 30 or higher, or
- A BMI of 27 or higher with at least one weight-related condition, such as high blood pressure, PCOS or acid reflux.
That means millions of people who aren't eligible through the NHS can still begin treatment with Juniper, without waiting years for the NHS rollout to expand.
Juniper's Weight Reset Programme provides a holistic approach by pairing medically backed treatments with habits that create lasting change. Research shows that without sufficient lifestyle change, some people gain back the weight after they stop taking weight loss medications [7].
Why choose Juniper?
With Juniper, members get unlimited support and can talk to health coaches, dietitians and pharmacists whenever they need help staying on track. We also provide the same wraparound support required by the NHS, including tailored diet, exercise and lifestyle coaching.
Our plans start from £125 per month—that’s just £31 per week for expert-led, medically backed weight care. Once approved, your medication is delivered discreetly to your door, as soon as the next day.
There’s no long waitlist. No GP referrals. Just fast, expert help when you’re ready.

in 1 year
- Clinically-backed weight loss treatments
- Personalised nutrition and exercise plan
- Trusted by 30,000 members around the world
- https://www.gov.uk/government/statistics/obesity-profile-update-may-2023/obesity-profile-short-statistical-commentary-may-2023
- https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
- https://www.nature.com/articles/s41591-022-02026-4
- https://www.nhs.uk/conditions/obesity/treatment/
- https://jamanetwork.com/journals/jama/fullarticle/2812936
- https://www.nice.org.uk/news/articles/consultation-on-nhs-england-proposals-for-a-phased-launch-of-obesity-injection
- https://pubmed.ncbi.nlm.nih.gov/35441470/